Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH.
Among privately insured women, diagnoses of postpartum anxiety and depression did not increase following onset of the COVID-19 pandemic, but there was an increase in the proportion of women filling a ...
Habitual coffee or caffeine intake is associated with a lower risk for new-onset cardiometabolic multimorbidity (CM).